The enzyme-activated irreversible inhibition of type-B monoamine oxidase by 3-(4-[(3-chlorophenyl)methoxy]phenyl)-5-[(methylamino) methyl]-2-oxazolidinone methanesulphonate (compound MD 780236) and the enzyme-catalysed oxidation of this compound as
about
Age-related changes in the activities of the amine metabolizing enzymes of rat eyeMonoamine oxidase-inhibiting properties of SR 95191, a new pyridazine derivative, in the rat: evidence for selective and reversible inhibition of monoamine oxidase type A in vivo but not in vitro.Identification of dihydroceramide desaturase as a direct in vitro target for fenretinide.Interactions of monoamine oxidase with substrates and inhibitors.Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs.The potential use of mechanism-based enzyme inactivators in medicine.Enzymology of monoamine oxidase.Selective inhibitors of monoamine oxidase A and B: biochemical, pharmacological, and clinical properties.Kinetics of suicide substrates. Practical procedures for determining parameters.Oxidation and enzyme-activated irreversible inhibition of rat liver monoamine oxidase-B by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).Monoamine oxidase-A selective inhibition in human hypothalamus and liver in-vitro by amiflamine and its metabolites.Age-related changes in benzylamine oxidase activity in rat tissues.Metabolism of the monoamine oxidase-B inhibitor, MD 780236 and its enantiomers by the A and B forms of the enzyme in the rat.
P2860
Q28577308-B272034D-BD51-4C03-A792-3C4A13DCCE76Q34175385-94E58167-8478-4D2C-BA3D-3D8F5C7CFC4AQ34182665-B76CF8A4-1167-4FBE-B8A5-8D7362718934Q38601497-08348A57-1FAB-4E75-9296-31B044B6371CQ39438767-62C03AF8-D524-4DD3-837F-37B1E376F8C3Q39568018-FF846888-E96C-4D0F-B440-D7B16E9007C8Q39733532-E5F3D825-A648-47BA-B7C3-4DCDA9FF7E60Q40182942-B56747CD-10B2-4E82-8584-DD772F7E99E4Q41822816-935E0EB2-E011-4DAB-8D21-EF6CF88F836BQ42854990-B95F6791-026F-42B7-A655-309385794C0CQ43734263-3EB31CF9-2940-4537-B0C9-B948E47EF5EDQ48630998-2B7443BA-C958-4D29-9ED2-F66A95A1D8F0Q48712942-079FF81E-099B-425F-A42E-BBA5E160716C
P2860
The enzyme-activated irreversible inhibition of type-B monoamine oxidase by 3-(4-[(3-chlorophenyl)methoxy]phenyl)-5-[(methylamino) methyl]-2-oxazolidinone methanesulphonate (compound MD 780236) and the enzyme-catalysed oxidation of this compound as
description
1983 nî lūn-bûn
@nan
1983 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
The enzyme-activated irreversi ...... oxidation of this compound as
@nl
type
label
The enzyme-activated irreversi ...... oxidation of this compound as
@nl
prefLabel
The enzyme-activated irreversi ...... oxidation of this compound as
@nl
P2093
P2860
P356
P1433
P1476
The enzyme-activated irreversi ...... ompound as competing reactions
@en
P2093
C J Fowler
J M McCrodden
K F Tipton
M Strolin Benedetti
P2860
P304
P356
10.1042/BJ2090235
P407
P577
1983-01-01T00:00:00Z